{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:33:52Z","timestamp":1786624432135,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ahjo.2026.100845","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:33:21Z","timestamp":1785281601000},"page":"100845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world long-term outcomes of clopidogrel-based dual antiplatelet therapy post-drug-eluting stent implantation in all comers patients: A retrospective evaluation"],"prefix":"10.1016","volume":"69","author":[{"given":"Rohan","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayshree","family":"Langade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Langade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ahjo.2026.100845_bb0005","doi-asserted-by":"crossref","first-page":"e1339","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990\u20132016","volume":"6","author":"Prabhakaran","year":"2018","journal-title":"Lancet Glob. Health"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100845_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.hjr.0000152239.28456.36","article-title":"The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study","volume":"11","author":"Lamy","year":"2004","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"25","key":"10.1016\/j.ahjo.2026.100845_bb0015","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100845_bb0020","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ahjo.2026.100845_bb0025","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100845_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf036","article-title":"Mortality and use of implantable cardioverter defibrillators in patients with low ejection fraction following non-ST-segment elevation myocardial infarction","volume":"27","author":"St\u00f8dkilde-J\u00f8rgensen","year":"2025","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ahjo.2026.100845_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258525","article-title":"Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.ahjo.2026.100845_bb0040","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100845_bb0045","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v4i2.758","article-title":"Aspirin-clopidogrel combination therapy for ischemic stroke patients: clinical efficacy and cost-effectiveness analyses in low-resource setting","volume":"4","author":"Fitria","year":"2024","journal-title":"Narra J."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100845_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2014.05.038","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke","volume":"22","author":"He","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100845_bb0055","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022","article-title":"A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke","volume":"23","author":"Yi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ahjo.2026.100845_bb0060","article-title":"Letter to \u201cShort-course potent P2Y12 inhibitor\u2013based DAPT versus clopidogrel-based DAPT after PCI: a propensity-matched real-world study.\u201d","author":"Zhao","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"11","key":"10.1016\/j.ahjo.2026.100845_bb0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/eurheartj\/ehac706","article-title":"Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials","volume":"44","author":"Costa","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100845_bb0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40001-023-01115-5","article-title":"A comparison of safety and efficacy between long-term DAPT and intensive statins combined with short-term DAPT for acute ischemic stroke","volume":"28","author":"Deng","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"11","key":"10.1016\/j.ahjo.2026.100845_bb0075","first-page":"63","article-title":"Positioning of the fixed dose combination of rosuvastatin + clopidogrel + aspirin in the treatment of cardiovascular diseases","volume":"120","author":"Bafna","year":"2022","journal-title":"J. Indian Med. Assoc."},{"issue":"18","key":"10.1016\/j.ahjo.2026.100845_bb0080","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100845_bb0085","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jacc.2016.03.512","article-title":"Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease","volume":"68","author":"Bittl","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.ahjo.2026.100845_bb0090","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ahjo.2026.100845_bb0095","article-title":"Short-course potent P2Y12 inhibitor\u2013based DAPT versus clopidogrel-based DAPT after PCI: a propensity-matched real-world study","author":"Kulsumritpon","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100845_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008525","article-title":"Randomized comparison of everolimus- and zotarolimus-eluting coronary stents with biolimus-eluting stents in all-comer patients","volume":"13","author":"Youn","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100845_bb0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4244\/EIJ-D-17-00468","article-title":"State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation \u2013 past, present and future perspectives","volume":"13","author":"Gargiulo","year":"2017","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.ahjo.2026.100845_bb0110","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4244\/EIJ-D-20-00999","article-title":"Lipid-lowering therapy and percutaneous coronary interventions","volume":"16","author":"Koskinas","year":"2021","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1016\/j.ahjo.2026.100845_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd12080300","article-title":"Intensive lipid-lowering therapy following acute coronary syndrome: the earlier the better","volume":"12","author":"Pradhan","year":"2025","journal-title":"JCDD"},{"issue":"23","key":"10.1016\/j.ahjo.2026.100845_bb0120","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.119.041766","article-title":"Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahjo.2026.100845_bb0125","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome \u2013 randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ. J."},{"issue":"44","key":"10.1016\/j.ahjo.2026.100845_bb0130","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry","volume":"37","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100845_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100845_bb0140","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0003319713500379","article-title":"Protective role of statins in patients with acute coronary syndrome aged \u226575 years with low LDL-C who underwent percutaneous coronary intervention","volume":"65","author":"Bu","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.ahjo.2026.100845_bb0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2023.02.004","article-title":"Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: a real-world national cohort analysis","volume":"377","author":"Salem","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"17","key":"10.1016\/j.ahjo.2026.100845_bb0150","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/ehw046","article-title":"Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100845_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s43044-025-00654-y","article-title":"Lipid profile and safety of rosuvastatin monotherapy versus rosuvastatin plus ezetimibe in high risk coronary artery disease: a systematic review and meta-analysis of randomized controlled trials","volume":"77","author":"Setyo Adji","year":"2025","journal-title":"Egypt. Heart J."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:59:20Z","timestamp":1786622360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S2666602226001333"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100845","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world long-term outcomes of clopidogrel-based dual antiplatelet therapy post-drug-eluting stent implantation in all comers patients: A retrospective evaluation","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100845"}}